Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | Chief Operating Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,401 |
Reported balance
After 2022-04-01 transaction · row 1
1 source rowRow 1 · 2022-04-01 · Tax withholding · Disposed 384 · Balance 47,401 F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2022 Filed Apr 5, 2022 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 384 | $52.91 | $20,317.44 |
DisclosureSEC source: 0001214659-22-004865 · marketforms-55954.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,401 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,124 | $53.21 | $59,808.04 |
DisclosureSEC source: 0001214659-22-003087 · marketforms-55523.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,785 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 24, 2022 Filed Jan 26, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 288 | $55.87 | $16,090.56 |
DisclosureSEC source: 0001214659-22-001138 · marketforms-55142.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,909 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 188 | $77.39 | $14,549.32 |
DisclosureSEC source: 0001214659-22-000944 · marketforms-55099.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,197 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 242 | $77.39 | $18,728.38 |
DisclosureSEC source: 0001214659-22-000331 · marketforms-54932.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,385 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 6,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-013754 · marketforms-54806.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,627 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of October 1, 2021, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,918 | $82.85 | $324,606.30 |
DisclosureSEC source: 0001214659-21-013607 · marketforms-54779.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,570 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 11, 2021. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 827 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-013286 · marketforms-54633.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,859 Underlying: Common Stock · 827 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,974 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-013286 · marketforms-54633.xml · derivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,376 Underlying: Common Stock · 1,974 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,801 | $84.00 | $235,284.00 |
DisclosureSEC source: 0001214659-21-013286 · marketforms-54633.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,488 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 11, 2021. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 827 | $25.02 | $20,691.54 |
DisclosureSEC source: 0001214659-21-013286 · marketforms-54633.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,974 | $26.66 | $52,626.84 |
DisclosureSEC source: 0001214659-21-013286 · marketforms-54633.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 827 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-012377 · marketforms-54406.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,686 Underlying: Common Stock · 827 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,974 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-012377 · marketforms-54406.xml · derivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,350 Underlying: Common Stock · 1,974 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,801 | $95.29 | $266,907.29 |
DisclosureSEC source: 0001214659-21-012377 · marketforms-54406.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,488 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 827 | $25.02 | $20,691.54 |
DisclosureSEC source: 0001214659-21-012377 · marketforms-54406.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,974 | $26.66 | $52,626.84 |
DisclosureSEC source: 0001214659-21-012377 · marketforms-54406.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,228 | $110.62 | $135,841.36 |
DisclosureSEC source: 0001214659-21-012188 · marketforms-54361.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,488 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 23:14 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 280 | $117.41 | $32,874.80 |
DisclosureSEC source: 0001214659-21-010778 · ownership.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,716 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 827 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-010534 · marketforms-54017.xml · derivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,513 Underlying: Common Stock · 827 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,974 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-010534 · marketforms-54017.xml · derivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,324 Underlying: Common Stock · 1,974 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,105 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-010534 · marketforms-54017.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,105 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,906 | $104.00 | $510,224.00 |
DisclosureSEC source: 0001214659-21-010534 · marketforms-54017.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,996 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 827 | $25.02 | $20,691.54 |
DisclosureSEC source: 0001214659-21-010534 · marketforms-54017.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,974 | $26.66 | $52,626.84 |
DisclosureSEC source: 0001214659-21-010534 · marketforms-54017.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 2,105 | $8.82 | $18,566.10 |
DisclosureSEC source: 0001214659-21-010534 · marketforms-54017.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 236 | $105.50 | $24,898.00 |
DisclosureSEC source: 0001214659-21-010287 · marketforms-53980.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,996 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 827 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-009618 · marketforms-53821.xml · derivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,340 Underlying: Common Stock · 827 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,974 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-009618 · marketforms-53821.xml · derivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,298 Underlying: Common Stock · 1,974 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,104 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-009618 · marketforms-53821.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,105 Underlying: Common Stock · 2,104 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,905 | $112.52 | $551,910.60 |
DisclosureSEC source: 0001214659-21-009618 · marketforms-53821.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,232 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 827 | $25.02 | $20,691.54 |
DisclosureSEC source: 0001214659-21-009618 · marketforms-53821.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,974 | $26.66 | $52,626.84 |
DisclosureSEC source: 0001214659-21-009618 · marketforms-53821.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:35 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 2,104 | $8.82 | $18,557.28 |
DisclosureSEC source: 0001214659-21-009618 · marketforms-53821.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,228 | $100.49 | $123,401.72 |
DisclosureSEC source: 0001214659-21-008949 · marketforms-53633.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,232 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 827 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-008867 · marketforms-53622.xml · derivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,167 Underlying: Common Stock · 827 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,974 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-008867 · marketforms-53622.xml · derivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,272 Underlying: Common Stock · 1,974 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,104 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-008867 · marketforms-53622.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,209 Underlying: Common Stock · 2,104 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,905 | $97.11 | $476,324.55 |
DisclosureSEC source: 0001214659-21-008867 · marketforms-53622.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,460 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 827 | $25.02 | $20,691.54 |
DisclosureSEC source: 0001214659-21-008867 · marketforms-53622.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,974 | $26.66 | $52,626.84 |
DisclosureSEC source: 0001214659-21-008867 · marketforms-53622.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 2,104 | $8.82 | $18,557.28 |
DisclosureSEC source: 0001214659-21-008867 · marketforms-53622.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2021 Filed Jul 27, 2021 21:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 280 | $117.34 | $32,855.20 |
DisclosureSEC source: 0001214659-21-007874 · marketforms-53384.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,460 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 827 | $0.00 Strike: $25.02 | $0.00 |
DisclosureSEC source: 0001214659-21-007789 · marketforms-53208.xml · derivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,994 Underlying: Common Stock · 827 shares Expires 2029-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,974 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-21-007789 · marketforms-53208.xml · derivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,246 Underlying: Common Stock · 1,974 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,104 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-21-007789 · marketforms-53208.xml · derivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,313 Underlying: Common Stock · 2,104 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,905 | $119.75 | $587,373.75 |
DisclosureSEC source: 0001214659-21-007789 · marketforms-53208.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,740 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 827 | $25.02 | $20,691.54 |
DisclosureSEC source: 0001214659-21-007789 · marketforms-53208.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 1,974 | $26.66 | $52,626.84 |
DisclosureSEC source: 0001214659-21-007789 · marketforms-53208.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:30 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 2,104 | $8.82 | $18,557.28 |
DisclosureSEC source: 0001214659-21-007789 · marketforms-53208.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.